NovaMedica team participates in the Russian Pharmaceutical Forum in St. Petersburg

31^st Russian Pharmaceutical Forum named after N.A. Semashko was launched in St. Petersburg today, May 14. Heads of pharmaceutical companies, government agencies and specialized associations are here to discuss the most pressing issues of the industry, give their assessments and forecasts, and propose ways to tackle challenges such as drug price regulation, elimination of shortages, development of API production in Russia, necessary government support measures, entering markets of friendly countries, etc. 

Forum participants note the high activity and engagement of representatives of foreign and domestic pharmaceutical companies in discussing current issues of price regulation, innovative activity of Russian manufacturers and search for export markets. 

NovaMedica is represented at the forum by its CEO and member of the Board of Directors Elena LITVINOVA and the Head of the company’s Business Unit Oksana KRASNYKH.

NovaMedica’s experts will participate in the discussion on optimizing timelines and budgets for creation of new drugs as part of the session “Clinical trials. Current situation in the Russian market. New challenges, pressing issues and solutions”. NovaMedica will also share its experience of interacting with the medical community and implementing the very important programs to improve diagnosis of CNS diseases at the session “Strategic marketing – increasing the efficiency of marketing campaigns in the changing landscape of the pharmaceutical industry”.